A de novo 2q37.2 deletion encompassing AGAP1 and SH3BP4 in a patient with autism and intellectual disability.

Eur J Med Genet 2018 Nov 22. Epub 2018 Nov 22.

CHU Nantes, Service de Génétique Médicale, Nantes, France; INSERM, UMR 1238, Bone Sarcoma and Remodeling of Calcified Tissue, Nantes, France.

Autism spectrum disorders are complex neurodevelopmental syndromes characterized by phenotypic and genetic heterogeneity. Further identification of causal genes may help in better understanding the underlying mechanisms of the disorder, thus improving the patients' management. To date, abnormal synaptogenesis is thought to be one of the major underlying causes of autism spectrum disorders. Here, using oligoarray-based comparative genomic hybridization, we identified a de novo deletion at 2q37.2 locus spanning 1 Mb and encompassing AGAP1 and SH3BP4, in a boy with autism and intellectual disability. Both genes have been described as being involved in endosomal trafficking, and AGAP1 in particular has been shown to be expressed in the developing brain and to play a role in dendritic spine formation and synapse function, making it a potential causative gene to our patient's phenotype.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejmg.2018.11.020DOI Listing
November 2018
6 Reads

Publication Analysis

Top Keywords

agap1 sh3bp4
8
autism spectrum
8
intellectual disability
8
autism intellectual
8
spectrum disorders
8
encompassing agap1
8
identified novo
4
hybridization identified
4
1 mb encompassing
4
sh3bp4 boy
4
spanning 1 mb
4
novo deletion
4
genomic hybridization
4
2q372 locus
4
locus spanning
4
deletion 2q372
4
comparative genomic
4
patients' management
4
management abnormal
4
improving patients'
4

Similar Publications